openPR Logo
Press release

Anticoagulants Market is boosted Due to Rise in Prevalence of Cardiovascular and Kidney Diseases | Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH and More

03-15-2019 09:24 AM CET | Health & Medicine

Press release from: Allied Market Research

Anticoagulants Market

Anticoagulants Market

According to a new report published by Allied Market Research, titled, Anticoagulants Market, by Drug Class, Route of Administration, Application: Global Opportunity Analysis and Industry Forecast, 2018-2025," the market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

Increase in prevalence of DVT, PE, and cardiac disease across the world plays a major role in the growth of the anticoagulant drugs market. Furthermore, increase in adoption of NOACs is expected to boost the demand for anticoagulants in the coming years.

North America accounted approximately one-half of the global market share in 2017 and is expected to remain dominant throughout the forecast period. This was attributed to the higher demand for novel therapeutics, strong presence of key players, early diagnosis, developed healthcare infrastructure, presence of trained medical professionals, and larger target population.

However, the Asia-Pacific region is expected to experience the highest growth rate during the forecast period, majorly owing to improving healthcare infrastructure with developing economies, rising diagnosis rate, enhancing health awareness, and increasing prevalence of cardiovascular disease and VTE.

Get Sample PDF Brochure of Anticoagulants Market Study at: https://www.alliedmarketresearch.com/request-sample/1673

On the basis of drug class, the anticoagulants market is segmented as NOACs, heparin & LMWH, vitamin K antagonist, and others. At present, the NOACs segment is a major revenue-generating segment and is anticipated to show dominance during the forecast period, owing to growing awareness of NOACs and rising use of NOACs over the warfarin. However, higher price of NOACs hinders the market growth.

As per the route of administration, the anticoagulants market is segmented as oral anticoagulant and injectable anticoagulant. At present, the oral anticoagulant segment is a major revenue-generating segment and is anticipated to show dominance during the forecast period, owing to growing adoption of NOACs and rising availability of lower cost warfarin.

The application market is categorized as atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. Presently, the atrial fibrillation & heart attack segment is a major revenue contributor and is anticipated to show dominance throughout the forecast period, owing to large target population and increase in use of anticoagulants to treat these conditions. However, the DVT segment is expected to show the fastest market growth, attributed to the increase in
prevalence of DVT and technological advancement in diagnosis of DVT.

Key Findings of the Anticoagulants Market:

• As per the drug class, the NOACs segment is expected to show the fastest market growth and grow at a CAGR of 8.0% from 2018 to 2025.
• On the basis of the route of administration, the oral anticoagulant segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
• By application, the deep vein thrombosis (DVT) segment is expected to exhibit the fastest growth at a CAGR of 8.4% from 2018 to 2025.
• Region-wise, the Asia-Pacific region is expected to experience growth at the highest rate, registering a CAGR of 9.2% during the forecast period.
Buy Now at: https://www.alliedmarketresearch.com/checkout/39236

About us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulants Market is boosted Due to Rise in Prevalence of Cardiovascular and Kidney Diseases | Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH and More here

News-ID: 1656327 • Views: 662

More Releases from Allied Market Research

Electric Passenger Car Traction Motor Market Growth 2027 – Key drivers, Busine …
Traction motor produces resistance between two surfaces with or without using electricity. An electric passenger car traction motor is a vital component which is used for extracting electricity from the battery pack. Traction motor is installed in electric passenger vehicles to provide rotation torque for the movement of the car. Furthermore, stringent emission discharge norms and regulations drives the demand for electric passenger car. Moreover, quick expansion of EV charging
Electric Passenger Car Lithium-Ion Battery Management System Market Analysis of …
Electric passenger car has gained a considerable consumer popularity & acceptance in the past few years. Major improvements in the performance of an electric passenger car such as high acceleration rate and long driving range after a single charge have been boosting the demand for electric passenger vehicle. Further, a lithium-ion battery (LIB) is a type of rechargeable battery, which is popularly used in the field of electric passenger vehicles
Electric Bus Door System Market Trending Technologies, Developments, Key Players …
Buses have had a strong place in the transportation industry since the 1830s when the first steam bus was introduced in London. Since the year 1830, buses are considered as the most common mode of public transportation in almost every country across the world. Electric bus door system is an assembly of interconnected mechanisms which utilizes the power of electricity to automatically open the door. Furthermore, the electric bus
Commercial Vehicle & Off-Highway RADAR Market Trends, Segments, Emerging Technol …
Commercial & off-highway vehicles are large and utilized for multiple tasks such as transport of goods, mining, excavation, and others. Due to their large sizes and complicated applications, these vehicles are prone to accidents. Safety concerns increase with a high number of blind spots, thereby propelling the use of RADARs in these vehicles to alert the driver of various threats. In addition, safety & security has become a topmost priority

All 5 Releases


More Releases for NOACs

US Anticoagulation Therapy Market|Key players in the US anticoagulation therapy …
The report "US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022", The US anticoagulation therapy market has witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 8.5% between 2017 and 2022 to reach USD 27.83 Billion by 2022.
Anticoagulants Market to extend at $43,427 Million, with a growing CAGR by 2025
The Anticoagulants Market was valued at $24,265 million in 2017, and is predicted to grow at $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. The global anticoagulants industry is anticipated to show significant growth during the forecast period, owing to increasing prevalence of venous thromboembolism (VTE) and cardiovascular disorders, growing adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs in the developing region.
Anticoagulants Market Value to Expand $43,427 Million by 2025, says AMR
The Global Anticoagulants Market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions, such as atrial
Anticoagulants Market Insights 2018-2025: Sanofi, Bristol-Myers Squibb, Bayer, J …
The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. The key players profiled in this report of anticoagulants market include Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer, Inc., Portola Pharmaceuticals, Inc., and Sanofi S.A. Anticoagulants
Anticoagulants Market Key Players : Aspen Holdings, Bayer AG, Boehringer Ingelhe …
The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions, such as atrial
US Anticoagulation Therapy Market to Reach US$ 27 Billion By 2022
Florida, January 16, 2018: Market Research Engine has published a new report titled as “US Anticoagulation Therapy Market By Product Type Analysis (US Anticoagulation Therapy (Products) Market, US Anticoagulation Therapy (Products) Market For PT/INR Testing Devices, US Anticoagulation Therapy Market For Clinics) and by Regional Analysis - Global Forecast by 2016 - 2022”. The growth within the anticoagulation medication market is primarily driven by the rising incidence of blood vessel occlusion,